Scientists are learning more about this leading complication of childbirth. Treatments are improving and doctors can test for ...
Data from the Phase 1 CARLYSLE study in severe refractory systemic lupus erythematosus (srSLE) suggests obe-cel is well tolerated with no ICANS or high-grade CRS; 50 million cell dose selected for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback